Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of +22.22% and -9.62%, respectively, for the quarter ended June 2025. Do the...
Vous n'êtes pas connecté
Rubriques :
- ZACKS.COM - All Stories - 11/Aug 23:00
Karyopharm Therapeutics (KPTI) Reports Q2 Loss, Lags Revenue Estimates
Karyopharm Therapeutics (KPTI) delivered earnings and revenue surprises of -13.68% and -5.37%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Articles similaires
BioXcel Therapeutics, Inc. (BTAI) Reports Q2 Loss, Lags Revenue Estimates
zacks.com - 12/Aug 19:00
BioXcel Therapeutics (BTAI) delivered earnings and revenue surprises of -6.52% and -52.00%, respectively, for the quarter ended June 2025. Do the...
BioXcel Therapeutics, Inc. (BTAI) Reports Q2 Loss, Lags Revenue Estimates
zacks.com - 12/Aug 19:00
BioXcel Therapeutics (BTAI) delivered earnings and revenue surprises of -6.52% and -52.00%, respectively, for the quarter ended June 2025. Do the...
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates
zacks.com - 14/Aug 13:15
VYNE Therapeutics (VYNE) delivered earnings and revenue surprises of +43.48% and -31.00%, respectively, for the quarter ended June 2025. Do the...
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates
zacks.com - 14/Aug 13:15
VYNE Therapeutics (VYNE) delivered earnings and revenue surprises of +43.48% and -31.00%, respectively, for the quarter ended June 2025. Do the...
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Tops Revenue Estimates
zacks.com - 11/Aug 22:55
Arcturus Therapeutics (ARCT) delivered earnings and revenue surprises of +69.37% and +20.84%, respectively, for the quarter ended June 2025. Do the...
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Tops Revenue Estimates
zacks.com - 12/Aug 19:00
ADC Therapeutics (ADCT) delivered earnings and revenue surprises of -38.89% and +0.58%, respectively, for the quarter ended June 2025. Do the numbers...
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Tops Revenue Estimates
zacks.com - 12/Aug 19:00
ADC Therapeutics (ADCT) delivered earnings and revenue surprises of -38.89% and +0.58%, respectively, for the quarter ended June 2025. Do the numbers...
TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Beats Revenue Estimates
zacks.com - 12/Aug 19:00
TScan Therapeutics (TCRX) delivered earnings and revenue surprises of 0.00% and +58.07%, respectively, for the quarter ended June 2025. Do the numbers...
TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Beats Revenue Estimates
zacks.com - 12/Aug 19:00
TScan Therapeutics (TCRX) delivered earnings and revenue surprises of 0.00% and +58.07%, respectively, for the quarter ended June 2025. Do the numbers...
Les derniers communiqués
-
NASA's Webb telescope discovers new moon orbiting Uranus
National Aeronautics and Space Administration - 22/08/2025
-
InventHelp Inventor Develops New Winter Hose Accessory (SGM-543)
Inventhelp - 22/08/2025
-
Netskope Files Registration Statement for Proposed Initial Public Offering
Netskope - 22/08/2025
-
Anesthesia and Respiratory Devices Market to Hit $74.8 Billion by 2030
BCC Research - 22/08/2025
-
RDDT Investors Have Opportunity to Lead Reddit, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Schall Law Firm - 18/08/2025
-
90% of Games Developers Already Using AI in Workflows, According to New Google Cloud Research
GOOGLE - 18/08/2025
-
Zerova Partners with Yunex Traffic to Strengthen After-Sales Support in the UK
Zerova - 18/08/2025
-
UFC 319: Chimaev wins middleweight championship
UFC - 18/08/2025
-
Siemba Named a Sample Vendor in Three 2025 Gartner® Hype Cycle™ Reports for the Second Year in a Row
Siemba - 16/08/2025
-
Faruqi & Faruqi Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025 – CAPR
Faruqi & Faruqi, LLP - 15/08/2025